Edges in Network
| Network | GSE12093_top500tf - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ALS2CR8 |
| Upstream (Parents) |
|---|
| (<<) ZFP36L2 → ALS2CR8 |
| (<<) HOXC10 → ALS2CR8 |
| (<<) CITED2 → ALS2CR8 |
| (<<) YY1 → ALS2CR8 |
| (<<) REL → ALS2CR8 |
| (<<) HEY2 → ALS2CR8 |
| (<<) RFXANK → ALS2CR8 |
| (<<) CNOT8 → ALS2CR8 |
| (<<) HHEX → ALS2CR8 |
| (<<) GATAD1 → ALS2CR8 |
| (<<) SCRT1 → ALS2CR8 |
| (<<) ZNF131 → ALS2CR8 |
| (<<) FOXK2 → ALS2CR8 |
| Downstream (Children) |
|---|
| ALS2CR8 → IRF4 (>>) |
| ALS2CR8 → IKZF1 (>>) |
| ALS2CR8 → EGR4 (>>) |
| ALS2CR8 → FOXM1 (>>) |
| ALS2CR8 → CREB5 (>>) |
| ALS2CR8 → NKX2-8 (>>) |
| ALS2CR8 → MTA2 (>>) |
| ALS2CR8 → TLX2 (>>) |
| ALS2CR8 → ARNTL2 (>>) |
| ALS2CR8 → FOXP3 (>>) |
| ALS2CR8 → ARID3A (>>) |
